AstraZeneca’s COVID-19 vaccination guidance for employees

As a science-led organisation, AstraZeneca fully supports the public health benefits of vaccination against COVID-19 for ourselves, and for the community at-large. Clinical trials and real-world evidence show that vaccination against COVID-19 significantly reduces the risk of hospitalisation, serious illness, and death.

Our number one priority continues to be the health and safety of our employees as well as the communities we work and live in. To that end, and after consultation with our people, AstraZeneca will now require all Australian staff with responsibilities that require face-to-face interactions with Health Care professionals and/or the general public to be fully vaccinated against COVID-19 by the end of November 2021. Our office is now open for any employees who are fully-vaccinated.

AstraZeneca continues to work closely with government and regulatory bodies, and with our employees, to ensure we fulfil our corporate responsibility to support and protect our people and our communities in this pandemic.

AU-12061 | Prepared October 2021